December 30, 2022
1 min read

India defends its pharma power

Bagchi, in his response further added that the MEA is extending consular assistance to individuals facing legal action from the Uzbek government…reports Asian Lite News

Keen to defend its reputation as the “pharmacy of the world”, India has launched a thorough investigation into allegations that 18 Uzbek children have died after consuming cough syrup manufactured by a Noida based company.

In response to a question about Uzbek deaths due to contaminated cough syrup Dok1 Max made by Indian company Marion Biotech based in Noida, MEA spokesperson Arindam Bagchi said: “Indian pharmaceutical industry has been a reliable supplier to countries across the world. It continues to be in various forms of medicine and other forms of pharmaceutical products.”  Bagchi added that, “We take these incidents very seriously when they come up. Let’s not jump the process.”

Earlier in a statement, the Health Ministry said following instructions from Health Minister Mansukh Mandaviya, the Central Drugs Standard Control Organisation (CDSCO) has established contact with Uzbekistan’s national drug regulator.

Besides, a joint inspection of the Marion Biotech facility was carried out by the UP Drug Control and CDSCO team. Based on the findings, further action as appropriate would be initiated based on the inspection report. The samples of the cough syrup have been taken to Regional Drugs Testing Laboratory (RDTL), Chandigarh for testing.

The health ministry said that Marion Biotech has a licence to manufacture and export Dok1 Max syrup and tablets.

Bagchi, in his response further added that the MEA is extending consular assistance to individuals facing legal action from the Uzbek government.

“We understand that legal action has been initiated by the Uzbek authorities against some people including the local representatives of the company there. In that context, we are extending consular assistance to those individuals,” he observed.

Bagchi pointed out that the Uzbek authorities had not formally taken up the matter with New Delhi. “Nevertheless, our embassy has taken up the case with the Uzbek side and is seeking further details of their own investigation,” he added.

ALSO READ: Indian-American named to US National Space Council advisory group

Previous Story

India seeks details of probe into cough syrup deaths

Next Story

Extended range Brahmos missile test fired from Sukhoi fighter

Latest from -Top News

ASEAN lauds India’s firm stance on terrorism

The ASEAN Secretary-General reaffirmed the bloc’s resolve to deepen collaboration with India—a comprehensive strategic partner—in security and counter-terrorism efforts. The Indian all-party Parliamentary delegation, led by Janata Dal (United) MP Sanjay Jha,

Ex-SEBI chief cleared by Lokpal

The anti-corruption ombudsman ruled that the complaints lacked credible evidence and were based largely on assumptions, speculation, and unverifiable claims. The Lokpal of India has dismissed all complaints against former Securities and

Iran pressed over 3 missing Indians

The embassy stated that it is maintaining close contact with the families and keeping them regularly updated about the steps being taken….reports Asian Lite News The Indian government has urged Iranian authorities

India-US eye June trade deal

The trade discussions come at a crucial time, with the United States’ 26 per cent reciprocal tariff on Indian goods—imposed on April 2—currently suspended until July 9….reports Asian Lite News India and
Go toTop

Don't Miss

India off to dominant start against Australia

Australia lost their last four wickets for 15 runs as

New Wave of IPOs Set to Hit Market

In the upcoming week (October 21-25), nine IPOs totaling Rs